Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes - Castle, Jessica R; Engle, Julia M; Youssef, Joseph El; Massoud, Ryan G; Yuen, Kevin C.J; Kagan, Ryland; Ward, W. Kenneth (Diabetes care, 2010)
Keywords: Accuracy; Adult; adults; adverse effects; analysis; Biological and medical sciences; blood glucose; Blood Glucose - analysis; Blood sugar; Diabetes; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 1 - drug therapy; Diabetes therapy; Diabetes. Impaired glucose tolerance; Diabetics; drug therapy; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Etiopathogenesis. Screening. Investigations. Target tissue resistance; FDA approval; Female; Glucagon; Glucagon - adverse effects; Glucagon - therapeutic use; glycemic control; Hormones; Hormones - adverse effects; Hormones - therapeutic use; Humans; hypoglycemia; Hypoglycemia - prevention & control; Insulin; insulin-dependent diabetes mellitus; Male; Medical sciences; Metabolic diseases; Miscellaneous; Original Research; Prevention; prevention & control; Public health. Hygiene; Public health. Hygiene-occupational medicine; Sensors; Studies; therapeutic use; Treatment Outcome; Type 1 diabetes; Endocrinopathy; Human; Immunopathology; Pancreatic hormone; Glucagon; Nutrition; Hyperglycemic substances; Use; Peptide hormone; Autoimmune disease; Metabolic diseases; Hypoglycemia; Prevention; Closed systems; Type 1 diabetes; Endocrinology